Ifenprodil

Ifenprodil

SCHEMBL34010

CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 7/20 1.00
ADRA1A P35348 6/20 1.00
ADRA2A P08913 5/20 1.00
HTR2A P28223 5/20 1.00
GRIN1 Q05586 5/20 1.00
HTR2B P41595 4/20 1.00
SIGMAR1 Q99720 3/20 1.00
GRIN2D O15399 3/20 1.00
GRIN2A Q12879 3/20 1.00
GRIN2C Q14957 3/20 1.00
CYP1A2 P05177 3/20 1.00
HTR1A P08908 2/20 1.00
MTOR P42345 2/20 1.00
GRIN3B O60391 2/20 1.00
CYP3A4 P08684 2/20 1.00
CYP2D6 P10635 2/20 1.00
GRIN3A Q8TCU5 2/20 1.00
LMNA P02545 2/20 1.00
ADRB1 P08588 1/20 1.00
DRD2 P14416 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ifenprodil SCHEMBL12496650 1.00 GRIN2B (1.00) GRIN2BADRA1AADRA2AHTR2AGRIN1
(R,S)-Ifenprodil SCHEMBL12618846 1.00 GRIN2B (1.00) GRIN2BADRA1AADRA2AHTR2AGRIN1
(R,S)-Ifenprodil SCHEMBL21614195 1.00 GRIN2B (1.00) GRIN2BADRA1AADRA2AHTR2AGRIN1
Ifenprodil SCHEMBL17654723 0.99 GRIN2B (0.97) GRIN2BADRA1AADRA2AHTR2AGRIN1
Ifenprodil SCHEMBL11159184 0.99 GRIN2B (0.97) GRIN2BADRA1AADRA2AHTR2AGRIN1
Ifenprodil SCHEMBL29237720 0.97 GRIN2B (0.95) GRIN2BADRA1AADRA2AHTR2AGRIN1
Ifenprodil SCHEMBL364019 0.93 GMNN (1.00) GRIN2BADRA1AADRA2AHTR2AGRIN1
Ifenprodil SCHEMBL1650040 0.93 GMNN (1.00) GRIN2BADRA1AADRA2AHTR2AGRIN1
Ifenprodil SCHEMBL21411500 0.92 GRIN2B (0.85) GRIN2BADRA1AADRA2AHTR2AGRIN1
SCHEMBL10735593 0.92 GRIN2B (0.85) GRIN2BADRA1AADRA2AHTR2AGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6488 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260139860-A1 PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS CENTRE FOR DIGESTIVE DISEASES (AU) 2026-05-21 US claimed
EP-4370202-B1 XENON GAS FOR USE IN THE TREATMENT OF GLIOMAS UNIV HEIDELBERG (DE) 2026-03-18 EP claimed
US-20260053750-A1 INHALABLE COMPOSITIONS OF CDK9 INHIBITORS OWEN MATTHEW (US) 2026-02-26 US claimed
EP-4680248-A1 PRODUCTS OF MANUFACTURE AND THERAPEUTIC COMPOSITIONS FOR TREATING, AMELIORATING OR PREVENTING VIRAL INFECTIONS AND METHODS FOR MAKING AND USING THEM Topelia Aust Limited (ACN 652 771 670) (AU) 2026-01-21 EP claimed
EP-4673157-A2 COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS, TREATMENT OF DYSBIOSIS AND DISEASE PREVENTION, AND METHODS FOR MAKING AND USING SAME Persephone Biosciences, Inc. (US) 2026-01-07 EP claimed
WO-2025264805-A2 SYNBIOTICS FOR MODULATING GUT MICROFLORA POPULATIONS, TREATMENT OF DYSBIOSIS AND DISEASE PREVENTION, AND METHODS FOR MAKING AND USING SAME PERSEPHONE BIOSCIENCES, INC. (US) 2025-12-26 WO claimed
WO-2025264860-A2 METHODS OF TREATING POST-COVID AIRWAY DISEASE YALE UNIVERSITY (US) 2025-12-26 WO claimed
US-12478618-B1 Use of glutamate 2B receptor antagonists and sigma receptor agonists as antitussives SEYLTX, INC. (US) 2025-11-25 US claimed
US-12472170-B2 Use of glutamate 2B receptor antagonists and sigma receptor agonists as antitussives SEYLTX, INC. (US) 2025-11-18 US claimed
US-20250333792-A1 GENE PANEL FOR IDENTIFYING HYPO SEPSIS PHENOTYPE PATIENTS UNIV FLORIDA (US) 2025-10-30 US claimed
WO-1995000478-A1 ARYLTRIFLATES AND RELATED COMPOUNDS LUNDBECK & CO AS H (DK) 1995-01-05 WO claimed
EP-0573581-A4 COMPOSITIONS AND METHODS OF TREATMENT OF SYMPATHETICALLY MAINTAINED PAIN ARC 1 INC (US) 1994-06-29 EP claimed
EP-0387751-B1 Medicated plasters NITTO DENKO CORP (JP) 1994-06-08 EP claimed
EP-0573581-A1 COMPOSITIONS AND METHODS OF TREATMENT OF SYMPATHETICALLY MAINTAINED PAIN ARC 1, Inc. (US) 1993-12-15 EP claimed
US-5145852-A Vaso-active medicament to treat impotence VIRAG RONALD (FR) 1992-09-08 US claimed
WO-1992014453-A1 COMPOSITIONS AND METHODS OF TREATMENT OF SYMPATHETICALLY MAINTAINED PAIN ARC 1, INC. (US) 1992-09-03 WO claimed
US-5039528-A EAA antagonists as anti-emetic drugs OLNEY JOHN W (US) 1991-08-13 US claimed
EP-0432994-A2 Excitatory amino acid antagonists as anti-emetic drugs Olney, John William (US) 1991-06-19 EP claimed
EP-0387751-A2 Medicated plasters NITTO DENKO CORPORATION (JP) 1990-09-19 EP claimed
US-4377691-A Process for the preparation of 1-(4-hydroxyphenyl)-2-(4-benzylpiperidino)-1-propanol and acid-addition salts thereof KABUSHIKI KAISHA COSMOS ENTERPRISE (JP) 1983-03-22 US claimed